Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 16, 2018
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 14
| |||||||
Eyepoint Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Theravance Biopharma, Inc.
| -16.10K |
$15.65 | -$251,980.65 | -8.10% | 182.73K | +1 |
Feb 20
| ||||||
Theravance Biopharma, Inc.
| -934.00 |
$12.98 | -$12,123.32 | -0.47% | 198.83K | +1 |
Aug 20
| ||||||
Theravance Biopharma, Inc.
| -7.36K |
$13.83 | -$101,788.80 | -3.55% | 199.77K | +1 |
Jun 2
| ||||||
Theravance Biopharma, Inc.
| -673.00 |
$14.24 | -$9,583.52 | -0.32% | 207.13K | +1 |
May 20
| ||||||
Theravance Biopharma, Inc.
| -674.00 |
$19.52 | -$13,156.48 | -0.32% | 207.8K | +1 |
Feb 20
| ||||||
Theravance Biopharma, Inc.
| 90K |
—
|
—
| +75.97% | 208.47K | +1 |
Feb 5
| ||||||
Theravance Biopharma, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Oct 8
| ||||||
Theravance Biopharma, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Theravance Inc
| -3.26K |
$22.76 | -$74,220.36 | -0.81% | 401.54K | +1 |
Aug 20
| ||||||
Theravance Inc
| 28.36K |
—
|
—
| +7.54% | 404.8K | +1 |
Jun 16
| ||||||
Theravance Inc
| 71K |
—
|
—
| +23.25% | 376.43K | +1 |
Jun 2
| ||||||
Theravance Inc
| -18.85K |
$26.86 | -$506,284.14 | -5.81% | 305.43K | +1 |
May 9
| ||||||
Theravance Inc
| 37.5K |
—
|
—
| +13.08% | 324.28K | +1 |
Apr 27
| ||||||
Theravance Inc
| -4.31K |
$39.98 | -$172,353.78 | -1.48% | 286.78K | +1 |
Feb 20
| ||||||
Theravance Inc
| 5K |
—
|
—
| +1.75% | 291.09K | +1 |
Jul 24
| ||||||
Theravance Inc
| -3.29K |
$37.01 | -$121,836.92 | -1.14% | 286.09K | +1 |
May 20
| ||||||
Theravance Inc
| 5K |
—
|
—
| +1.76% | 289.39K | +1 |
Feb 7
| ||||||
Theravance Inc
| 5K |
—
|
—
| +1.79% | 284.39K | +1 |
Oct 15
| ||||||
Theravance Inc
| -7.55K |
$29.69 | -$224,040.74 | -2.63% | 279.39K | +1 |
Jul 30
| ||||||
Theravance Inc
| 5K |
—
|
—
| +1.77% | 286.93K | +1 |
Feb 15
| ||||||
Theravance Inc
| 112.5K |
—
|
—
| +66.40% | 281.93K | +1 |
Feb 11
| ||||||
Theravance Inc
| 12.5K |
—
|
—
| +7.97% | 169.43K | +1 |
Oct 26
| ||||||
Theravance Inc
| -1.69K |
$13.02 | -$21,951.72 | -1.06% | 156.93K | +1 |
May 20
| ||||||
Theravance Inc
| 12.7K |
$10.47 | $133,015.41 | +8.71% | 158.62K | +1 |
Feb 24 - Feb 25
| ||||||
Theravance Inc
| -1.33K |
$10.22 | -$13,643.70 | -0.91% | 145.92K | +1 |
Feb 20
| ||||||
Theravance Inc
| 25K |
—
|
—
| +20.45% | 147.25K | +1 |
Feb 10
| ||||||
Theravance Inc
| -1.11K |
$14.04 | -$15,640.56 | -0.90% | 122.25K | +1 |
Nov 20
| ||||||
Theravance Inc
| -1.08K |
$15.65 | -$16,964.60 | -0.87% | 123.36K | +1 |
Aug 20
| ||||||
Theravance Inc
| -1.09K |
$14.06 | -$15,269.16 | -0.87% | 124.45K | +1 |
May 20
| ||||||
Theravance Inc
| 35K |
—
|
—
| +38.66% | 125.53K | +1 |
Mar 20
| ||||||
Theravance Inc
| -1.46K |
$14.87 | -$21,725.07 | -1.59% | 90.53K | +1 |
Feb 20
| ||||||
Theravance Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Jul 23
| ||||||
Theravance Inc
| 28.39K |
$10.84 | $307,698.45 | +44.62% | 92K | +1 |
Mar 10
| ||||||
Theravance Inc
| 13.61K |
—
|
—
| +27.22% | 63.61K | +1 |
Jan 29
| ||||||
Theravance Inc
| 50K |
—
|
—
|
∞
| 50K | +1 |
Aug 1
| ||||||
Theravance Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Icos Corp
| -92.63K |
$34.00 | -$3,149,386.00 | -100.00% |
0
| +1 |
Jan 29
| ||||||
Icos Corp
| -571.00 |
$33.90 | -$19,356.90 | -0.66% | 85.83K | +1 |
Jan 24
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.